LMNB1 and carcinoma of esophagus: Its noteworthy that loss of Lamin B1 expression was identified in different malignant tissue such as prostate, breast and esophageal carcinoma [69], indicating that the decline of Lamin B1 expression might be considered a malignancy biomarker.